Meihua Medical (MHUA): רווח למניה בשנים עשר החודשים האחרונים

MeihuaMed (MHUA) is developing partnerships with global distributors for the supply of consumables, while the GURU.Markets terminal provides the rolling 12-month earnings per share, where 31.06 serves as the final level mark. China's stable medtech sector allows MeihuaMed (MHUA) to retain skilled engineers. Simultaneously, the business is optimizing its polymer supplier pool to reduce operational dependence on external vendors.

This indicator reflects the actual return on each share of capital by dividing total net income by the total number of shares. The trailing 12-month (TTM) calculation neutralizes seasonality, allowing for the real-time tracking of profit dynamics. By analyzing the TTM net income per share, an investor can gauge the efficiency of cost management. For MeihuaMed (MHUA), growth in this metric confirms the success of its expansion into Western markets. The automation of medical device production converts directly into an increase in this per-share indicator.